Conference abstract · 21 Jun 2018
Research articlePublished 28 Aug 2020
Quality risk management system
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the pharmaceutical industry every product and every process associated with risks. To maintain product quality throughout the product life cycle, too much time and resources are allocated. Risk is described in - recent guidance as a combination of the probability of occurrence of harm and the severity of that harm. The Quality Risk Management (QRM) approach initiated by regulatory agencies with recognized management tools along with support of statistical tools in combination allows for a risk-based approach to quality management, thus ensuring that resources are deployed in a timely and expeditious manner to areas that need them most. QRM improves risk awareness and accelerates detection of potential issues by analyzing and comparing existing data from a quality perspective to manage product quality, manufacturing processes, validation and compliance within a risk based Quality Management System. In addition quality risk management improves decision making if a quality problem arises. It should include systemic processes designated to coordinate, facilitate and improve science-based decision-making with respect to risk. Quality Risk Management can be applied not only in the manufacturing environment, but also in connection with pharmaceutical development and preparation of the quality part of marketing authorization dossiers. The guideline applies also to the regulatory authorities in the fields of pharmaceutical assessment of the quality part of the marketing authorization dossier, GMP inspections and the handling of suspected quality defects. ICH Q9 - Quality Risk Management provides an excellent high-level framework for the use of risk management in pharmaceutical product development and manufacturing quality decision making applications. It is a landmark document in acknowledging risk management as a standard and acceptable quality system practice to facilitate good decision-making with regard to risk identification, resource prioritization and risk mitigation / elimination, as appropriate.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
Quality risk management system
Conference abstract · 25 Sep 2017
Quality risk management system
Conference abstract · 12 Aug 2016
Quality risk management system
Conference abstract · 3 Aug 2015
Quality risk management system
More from this journal
The newest in Der Pharmacia Sinica.
Commentary · 31 Jan 2025
Phytochemical Analysis and Pharmacological Potential of Traditional Medicinal Plants: An Integrative Approach
Brief report · 31 Jan 2025
Formulation and Evaluation of Novel Herbal Nanoemulsions for Enhanced Drug Delivery
Perspective · 31 Jan 2025
Green Synthesis of Metal Nanoparticles Using Medicinal Herbs: Applications in Antimicrobial Therapy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Sinica
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Asghar Shahbaz”

